AVIR vs BKNG · $353.7M cap vs P/E 36, rev $7.35B
Atea Pharmaceuticals Inc (AVIR) versus Booking Holdings Inc (BKNG) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
AVIR does not have a complete income-statement cache yet.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
AVIR currently screens at market cap $353.7M. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Not investment advice. Open the AVIR and BKNG stock pages for the full models.
Not investment advice.